STOCK TITAN

[SCHEDULE 13G/A] ProQR Therapeutics N.V. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Adage Capital Management reports a passive beneficial ownership position in ProQR Therapeutics N.V., holding 6,601,938 ordinary shares, which represents 6.27% of the company's 105,212,527 ordinary shares outstanding (per the company's annual report). The shares are held directly by Adage Capital Partners, L.P., for which Adage Capital Management acts as investment manager, and the filing shows shared voting and shared dispositive power for the reported position.

The Schedule 13G filing is made as a passive disclosure: the Reporting Persons certify the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. The filing names the reporting entities and key individuals and identifies their principal business address.

Adage Capital Management comunica una partecipazione economica passiva in ProQR Therapeutics N.V., detenendo 6.601.938 azioni ordinarie, pari al 6,27% delle 105.212.527 azioni ordinarie in circolazione della società (secondo il rapporto annuale della società). Le azioni sono detenute direttamente da Adage Capital Partners, L.P., per la quale Adage Capital Management agisce come gestore degli investimenti, e la comunicazione indica potere di voto e potere dispositivo condivisi per la posizione segnalata.

La presentazione del modulo Schedule 13G è effettuata come comunicazione passiva: le persone che segnalano certificano che i titoli sono stati acquisiti e sono detenuti nell'ordinario corso dell'attività e non allo scopo di modificare o influenzare il controllo dell'emittente. Il documento indica le entità segnalanti e i soggetti chiave e riporta il loro indirizzo professionale principale.

Adage Capital Management informa de una posición de propiedad beneficiaria pasiva en ProQR Therapeutics N.V., poseyendo 6.601.938 acciones ordinarias, lo que representa el 6,27% de las 105.212.527 acciones ordinarias en circulación de la compañía (según el informe anual de la empresa). Las acciones están en propiedad directa de Adage Capital Partners, L.P., para la cual Adage Capital Management actúa como gestor de inversiones, y la presentación muestra poder de voto compartido y poder dispositivo compartido respecto a la posición declarada.

La presentación del Schedule 13G se realiza como una divulgación pasiva: las personas informantes certifican que los valores fueron adquiridos y se mantienen en el curso ordinario del negocio y no con el propósito de cambiar o influir en el control del emisor. La presentación nombra a las entidades informantes y a las personas clave e identifica su dirección comercial principal.

Adage Capital Management는 ProQR Therapeutics N.V.에 대한 수동적 수익권 보유를 보고했습니다. 보유 주식은 6,601,938 보통주로 회사의 총 105,212,527 보통주 중 6.27%에 해당합니다(회사 연례보고서 기준). 해당 주식은 Adage Capital Management가 투자매니저로 활동하는 Adage Capital Partners, L.P.에 의해 직접 보유되며, 제출 서류에는 보고된 지분에 대해 의결권 공동 보유 및 처분권 공동 보유가 표시되어 있습니다.

Schedule 13G 제출은 수동적 공시로 이루어졌습니다. 보고자는 해당 증권이 영업의 통상적 범위에서 취득·보유된 것이며 발행인의 지배권을 변경하거나 영향을 미칠 목적이 아님을 확인합니다. 제출서에는 보고 법인과 주요 개인들이 명시되어 있으며 그들의 주요 영업 주소가 기재되어 있습니다.

Adage Capital Management déclare une position de propriété bénéficiaire passive dans ProQR Therapeutics N.V., détenant 6 601 938 actions ordinaires, ce qui représente 6,27% des 105 212 527 actions ordinaires en circulation de la société (selon le rapport annuel de la société). Les actions sont détenues directement par Adage Capital Partners, L.P., pour laquelle Adage Capital Management agit en tant que gestionnaire d'investissement, et le dépôt indique un pouvoir de vote partagé et un pouvoir dispositif partagé pour la position déclarée.

Le dépôt du formulaire Schedule 13G est effectué en tant que divulgation passive : les personnes déclarante certifient que les titres ont été acquis et sont détenus dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contrôle de l'émetteur. Le dépôt nomme les entités déclarante et les personnes clés et identifie leur adresse professionnelle principale.

Adage Capital Management meldet eine passive wirtschaftliche Eigentümerstellung an ProQR Therapeutics N.V. und hält 6.601.938 Stammaktien, was 6,27% der insgesamt 105.212.527 ausstehenden Stammaktien des Unternehmens entspricht (laut Geschäftsbericht des Unternehmens). Die Aktien werden direkt von Adage Capital Partners, L.P. gehalten, für die Adage Capital Management als Investmentmanager tätig ist, und die Meldung weist für die gemeldete Position ein gemeinsames Stimm- und gemeinsames Verfügungsrecht aus.

Die Einreichung des Schedule 13G erfolgt als passive Offenlegung: die berichtenden Personen bestätigen, dass die Wertpapiere im normalen Geschäftsverlauf erworben und gehalten werden und nicht mit dem Ziel, die Kontrolle des Emittenten zu ändern oder zu beeinflussen. Die Meldung nennt die berichtenden Einheiten und Schlüsselpersonen und gibt deren Hauptgeschäftsanschrift an.

Positive
  • Adage holds 6,601,938 shares, representing 6.27% of ProQR's outstanding ordinary shares
  • Position filed on Schedule 13G indicating the holding is passive and certified not to be for control purposes
Negative
  • None.

Insights

Adage holds a meaningful 6.27% passive stake in ProQR; this shows notable institutional interest without an intent to seize control.

The 6,601,938-share position equals 6.27% of the 105,212,527 shares referenced in the company's annual report, a level that typically warrants market attention because it crosses the 5% disclosure threshold. As this Schedule 13G indicates passive ownership, there is no stated plan to pursue control, which reduces immediate governance disruption risk. For investors, the disclosure signals that a seasoned institutional manager has a sizable economic exposure to PRQR equity, which may influence liquidity and monitoring activities but is not presented as an activist stake.

This is a material ownership disclosure (>5%) filed as passive; it raises governance monitoring but does not indicate an intent to change control.

The filing attributes shared voting and shared dispositive power over 6,601,938 ordinary shares held by an affiliate structure (Adage Capital Partners, L.P.). Filing on Schedule 13G and the included certification state the position is held in the ordinary course and not to influence control, which classifies the holder as a passive institutional investor rather than an activist. Materiality arises from the >5% threshold, meaning the holder will be visible to other stakeholders and subject to public scrutiny, but the filing itself contains no operational or governance demands.

Adage Capital Management comunica una partecipazione economica passiva in ProQR Therapeutics N.V., detenendo 6.601.938 azioni ordinarie, pari al 6,27% delle 105.212.527 azioni ordinarie in circolazione della società (secondo il rapporto annuale della società). Le azioni sono detenute direttamente da Adage Capital Partners, L.P., per la quale Adage Capital Management agisce come gestore degli investimenti, e la comunicazione indica potere di voto e potere dispositivo condivisi per la posizione segnalata.

La presentazione del modulo Schedule 13G è effettuata come comunicazione passiva: le persone che segnalano certificano che i titoli sono stati acquisiti e sono detenuti nell'ordinario corso dell'attività e non allo scopo di modificare o influenzare il controllo dell'emittente. Il documento indica le entità segnalanti e i soggetti chiave e riporta il loro indirizzo professionale principale.

Adage Capital Management informa de una posición de propiedad beneficiaria pasiva en ProQR Therapeutics N.V., poseyendo 6.601.938 acciones ordinarias, lo que representa el 6,27% de las 105.212.527 acciones ordinarias en circulación de la compañía (según el informe anual de la empresa). Las acciones están en propiedad directa de Adage Capital Partners, L.P., para la cual Adage Capital Management actúa como gestor de inversiones, y la presentación muestra poder de voto compartido y poder dispositivo compartido respecto a la posición declarada.

La presentación del Schedule 13G se realiza como una divulgación pasiva: las personas informantes certifican que los valores fueron adquiridos y se mantienen en el curso ordinario del negocio y no con el propósito de cambiar o influir en el control del emisor. La presentación nombra a las entidades informantes y a las personas clave e identifica su dirección comercial principal.

Adage Capital Management는 ProQR Therapeutics N.V.에 대한 수동적 수익권 보유를 보고했습니다. 보유 주식은 6,601,938 보통주로 회사의 총 105,212,527 보통주 중 6.27%에 해당합니다(회사 연례보고서 기준). 해당 주식은 Adage Capital Management가 투자매니저로 활동하는 Adage Capital Partners, L.P.에 의해 직접 보유되며, 제출 서류에는 보고된 지분에 대해 의결권 공동 보유 및 처분권 공동 보유가 표시되어 있습니다.

Schedule 13G 제출은 수동적 공시로 이루어졌습니다. 보고자는 해당 증권이 영업의 통상적 범위에서 취득·보유된 것이며 발행인의 지배권을 변경하거나 영향을 미칠 목적이 아님을 확인합니다. 제출서에는 보고 법인과 주요 개인들이 명시되어 있으며 그들의 주요 영업 주소가 기재되어 있습니다.

Adage Capital Management déclare une position de propriété bénéficiaire passive dans ProQR Therapeutics N.V., détenant 6 601 938 actions ordinaires, ce qui représente 6,27% des 105 212 527 actions ordinaires en circulation de la société (selon le rapport annuel de la société). Les actions sont détenues directement par Adage Capital Partners, L.P., pour laquelle Adage Capital Management agit en tant que gestionnaire d'investissement, et le dépôt indique un pouvoir de vote partagé et un pouvoir dispositif partagé pour la position déclarée.

Le dépôt du formulaire Schedule 13G est effectué en tant que divulgation passive : les personnes déclarante certifient que les titres ont été acquis et sont détenus dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contrôle de l'émetteur. Le dépôt nomme les entités déclarante et les personnes clés et identifie leur adresse professionnelle principale.

Adage Capital Management meldet eine passive wirtschaftliche Eigentümerstellung an ProQR Therapeutics N.V. und hält 6.601.938 Stammaktien, was 6,27% der insgesamt 105.212.527 ausstehenden Stammaktien des Unternehmens entspricht (laut Geschäftsbericht des Unternehmens). Die Aktien werden direkt von Adage Capital Partners, L.P. gehalten, für die Adage Capital Management als Investmentmanager tätig ist, und die Meldung weist für die gemeldete Position ein gemeinsames Stimm- und gemeinsames Verfügungsrecht aus.

Die Einreichung des Schedule 13G erfolgt als passive Offenlegung: die berichtenden Personen bestätigen, dass die Wertpapiere im normalen Geschäftsverlauf erworben und gehalten werden und nicht mit dem Ziel, die Kontrolle des Emittenten zu ändern oder zu beeinflussen. Die Meldung nennt die berichtenden Einheiten und Schlüsselpersonen und gibt deren Hauptgeschäftsanschrift an.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Adage Capital Management, L.P.
Signature:/s/ Robert Atchinson
Name/Title:By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member
Date:08/12/2025
Robert Atchinson
Signature:/s/ Robert Atchinson
Name/Title:Robert Atchinson, individually
Date:08/12/2025
Phillip Gross
Signature:/s/ Phillip Gross
Name/Title:Phillip Gross, individually
Date:08/12/2025

FAQ

How many ProQR (PRQR) shares does Adage Capital report owning?

Adage Capital reports beneficial ownership of 6,601,938 ordinary shares of ProQR.

What percentage of ProQR does Adage's holding represent?

The reported position represents 6.27% of the class, based on 105,212,527 shares referenced in the filing.

Is Adage reporting the stake as passive or active ownership?

The stake is reported on Schedule 13G and the Reporting Persons certify the securities are held in the ordinary course of business and not to influence control.

Through which entity are the shares held?

The ordinary shares are directly held by Adage Capital Partners, L.P., for which Adage Capital Management, L.P. acts as investment manager.

Who are the named reporting persons in the filing?

The filing names Adage Capital Management, L.P., and individuals Robert Atchinson and Phillip Gross as Reporting Persons.
Proqr Therapeuti

NASDAQ:PRQR

PRQR Rankings

PRQR Latest News

PRQR Latest SEC Filings

PRQR Stock Data

212.79M
86.34M
18.06%
50.89%
0.41%
Biotechnology
Healthcare
Link
Netherlands
Leiden